Last reviewed · How we verify
Relapse multiple myeloma
Approved treatments
- Kyprolis · Black Sea Hematology Association
- Blenrep · Duke University
- Blenrep · GSK
Belantamab mafodotin binds to BCMA on multiple myeloma cells, is internalized, and releases a cytotoxic agent that disrupts microtubules, causing cell death. - Kyprolis · Amgen
Kyprolis works by blocking the proteasome, a complex that breaks down proteins in cells. - Huluc63 · Bristol-Myers Squibb
Huluc63 works by binding to the SLAMF7 protein on the surface of cancer cells, stimulating the immune system to attack and kill the cells.
Clinical guidelines
- FDA label — 3L+
EMPLICITI in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Relapse multiple myeloma patent landscape — cliff calendar, originator estates, attackable patents
- Relapse multiple myeloma treatment landscape brief
- Relapse multiple myeloma treatment updates RSS
Frequently asked questions about Relapse multiple myeloma
What drugs treat Relapse multiple myeloma?
Tracked treatments include Kyprolis, Blenrep, Huluc63.
What is the treatment for Relapse multiple myeloma?
Standard treatment for Relapse multiple myeloma includes Kyprolis, Blenrep, Huluc63. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Relapse multiple myeloma?
FDA label publishes guidelines for Relapse multiple myeloma. 1 guideline references tracked.
Related
- Treatment landscape: Relapse multiple myeloma patent cliff · Relapse multiple myeloma CI report
- Treatment: Kyprolis · Black Sea Hematology Association
- Treatment: Blenrep · Duke University
- Treatment: Blenrep · GSK
- Treatment: Kyprolis · Amgen
- Treatment: Huluc63 · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing